Gary Elfring

9.4k citations
93 papers · 5.9k · 1 hit paper · h-index 27

Impact in

  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Oncology top 0.5%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology

Papers in

    • Muscle Physiology and Disorders 40
    • Cancer therapeutics and mechanisms 14
    • Colorectal Cancer Treatments and Studies 9
    • Lung Cancer Research Studies 9
    • Cancer Treatment and Pharmacology 6

Gary Elfring

87 papers receiving 5.7k citations

Gary Elfring's Hit Papers

Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer 2000 · 2.4k citations
2.4k0+8+17Years since publication50010001.5k2.0k

Peers

Gary Elfring
Comparison fields: 5 of 121
  • Hepatology 1.0k
  • Oncology 3.1k
  • Genetics 510
  • Pulmonary and Respiratory Medicine 1.5k
  • Molecular Biology 2.4k
Replace Langdon L. Miller with:
Langdon L. Miller United States
Peter J. Rosen United States
Tsu-Yi Chao Taiwan
Eric Jonasch United States
John Hamm United States
David J. Vaughn United States
Evaristo Maiello Italy
Francesco Cognetti Italy
Yutaka Fujiwara Japan
Myung Ah Lee South Korea
Gary Elfring relative to Langdon L. Miller United States Langdon L. Miller's profile →
Citations per field
00.5×1.5×
Langdon L. Miller · 1×
Citations per year

Countries citing papers authored by Gary Elfring

Since Specialization
Citations

This map shows the geographic impact of Gary Elfring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Elfring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Elfring more than expected).

Fields of papers citing papers by Gary Elfring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Elfring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Elfring. The network helps show where Gary Elfring may publish in the future.

Co-authors

The 25 scholars most cited alongside Gary Elfring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary Elfring Line = papers co-authored together Gary Elfring links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
Hit paper breakdown →
20002368
2 1996305
3 2008290
4 2009283
5 2007267
6 2013224
7 2007188
8 2010184
9 2013172
10 1999162
11 2011151
12 2010131
13 2001117
14 200388
15 199985
16 201369
17
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy.
200065
18 200264
19 197362
20 199961

About Gary Elfring

Gary Elfring is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cell Biology and Genetics, having authored 93 papers that have together received 5.9k indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (40 papers), Cancer therapeutics and mechanisms (14 papers), Cystic Fibrosis Research Advances (9 papers), Colorectal Cancer Treatments and Studies (9 papers), Lung Cancer Research Studies (9 papers), Cancer Treatment and Pharmacology (6 papers), Biotin and Related Studies (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). The work is most often cited by research in Hepatology (1.0k citations), Oncology (3.1k citations), Genetics (510 citations), Pulmonary and Respiratory Medicine (1.5k citations) and Molecular Biology (2.4k citations). Gary Elfring has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Langdon L. Miller, Paula K. Locker, Leonard B. Saltz, Nicoletta Pirotta, John V. Cox, Louis Fehrenbacher, Jean A. Maroun, Lee S. Rosen, Malcolm J. Moore and Charles D. Blanke. Their work appears in journals such as Neuromuscular Disorders, Journal of Clinical Oncology, Journal of Cystic Fibrosis, Neurology and Muscle & Nerve.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact